Tag: Intensive Care

Plasma with neutralizing antibody titer of at least 1:160 reduces mortality at 28 days versus standard care

Infection-related ventilator-associated complications may occur in fewer patients receiving amikacin

A. baumannii, CRAB, C. auris colonization more likely among patients in long-term care facilities than acute care hospitals

Variability seen in RBC transfusion practices

Decrease seen in RBC units per patient after transition from standard- to small-volume tubes

Updated recommendations integrate guidance for adults and children into a single guideline

A mortality prediction model lost 9 to 39 percent specificity after retraining once at a fixed sensitivity of 90 percent

However, no reduction seen in ventilatory support or oxygen therapy for those younger than 5 years

Those using recreational drugs have higher rate of in-hospital major adverse events

Model with serial ammonia measured on ICU days 1 and 3 predicted hospital mortality with reasonably good discrimination